The Texas medication algorithm project: Report of the Texas consensus conference panel on medication treatment of major depressive disorder

M. Lynn Crismon, Madhukar Trivedi, Teresa A. Pigott, A. John Rush, Robert M A Hirschfeld, David A. Kahn, Charles DeBattista, J. Craig Nelson, Andrew A. Nierenberg, Harold A. Sackeim, Michael E. Thase

Research output: Contribution to journalArticle

232 Citations (Scopus)

Abstract

Background: This article describes the development of consensus medication algorithms for the treatment of patients with major depressive disorder in the Texas public mental health system. To the best of our knowledge, the Texas Medication Algorithm Project (TMAP) is the first attempt to develop and prospectively evaluate consensus-based medication algorithms for the treatment of individuals with severe and persistent mental illnesses. The goals of the algorithm project are to increase the consistency of appropriate treatment of major depressive disorder and to improve clinical outcomes of patients with the disorder. Method: A consensus conference composed of academic clinicians and researchers, practicing clinicians, administrators, consumers, and families was convened to develop evidence- based consensus algorithms for the pharmacotherapy of major depressive disorder in the Texas mental health system. After a series of presentations and panel discussions, the consensus panel met and drafted the algorithms. Results: The panel consensually agreed on algorithms developed for both nonpsychotic and psychotic depression. The algorithms consist of systematic strategies to define appropriate treatment interventions and tactics to assure optimal implementation of the strategies. Subsequent to the consensus process, the algorithms were further modified and expanded iteratively to facilitate implementation on a local basis. Conclusion: These algorithms serve as the initial foundation for the development and implementation of medication treatment algorithms for patients treated in public mental health systems. Specific issues related to adaptation, implementation, feasibility testing, and evaluation of outcomes with the pharmacotherapeutic algorithms will be described in future articles.

Original languageEnglish (US)
Pages (from-to)142-156
Number of pages15
JournalJournal of Clinical Psychiatry
Volume60
Issue number3
StatePublished - Mar 1999

Fingerprint

Major Depressive Disorder
Consensus
Therapeutics
Mental Health
Public Health
Administrative Personnel
Research Personnel
Depression

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Clinical Psychology

Cite this

Crismon, M. L., Trivedi, M., Pigott, T. A., Rush, A. J., Hirschfeld, R. M. A., Kahn, D. A., ... Thase, M. E. (1999). The Texas medication algorithm project: Report of the Texas consensus conference panel on medication treatment of major depressive disorder. Journal of Clinical Psychiatry, 60(3), 142-156.

The Texas medication algorithm project : Report of the Texas consensus conference panel on medication treatment of major depressive disorder. / Crismon, M. Lynn; Trivedi, Madhukar; Pigott, Teresa A.; Rush, A. John; Hirschfeld, Robert M A; Kahn, David A.; DeBattista, Charles; Nelson, J. Craig; Nierenberg, Andrew A.; Sackeim, Harold A.; Thase, Michael E.

In: Journal of Clinical Psychiatry, Vol. 60, No. 3, 03.1999, p. 142-156.

Research output: Contribution to journalArticle

Crismon, ML, Trivedi, M, Pigott, TA, Rush, AJ, Hirschfeld, RMA, Kahn, DA, DeBattista, C, Nelson, JC, Nierenberg, AA, Sackeim, HA & Thase, ME 1999, 'The Texas medication algorithm project: Report of the Texas consensus conference panel on medication treatment of major depressive disorder', Journal of Clinical Psychiatry, vol. 60, no. 3, pp. 142-156.
Crismon, M. Lynn ; Trivedi, Madhukar ; Pigott, Teresa A. ; Rush, A. John ; Hirschfeld, Robert M A ; Kahn, David A. ; DeBattista, Charles ; Nelson, J. Craig ; Nierenberg, Andrew A. ; Sackeim, Harold A. ; Thase, Michael E. / The Texas medication algorithm project : Report of the Texas consensus conference panel on medication treatment of major depressive disorder. In: Journal of Clinical Psychiatry. 1999 ; Vol. 60, No. 3. pp. 142-156.
@article{c82b1ba8dc8f40d5bbd32d3d73aac955,
title = "The Texas medication algorithm project: Report of the Texas consensus conference panel on medication treatment of major depressive disorder",
abstract = "Background: This article describes the development of consensus medication algorithms for the treatment of patients with major depressive disorder in the Texas public mental health system. To the best of our knowledge, the Texas Medication Algorithm Project (TMAP) is the first attempt to develop and prospectively evaluate consensus-based medication algorithms for the treatment of individuals with severe and persistent mental illnesses. The goals of the algorithm project are to increase the consistency of appropriate treatment of major depressive disorder and to improve clinical outcomes of patients with the disorder. Method: A consensus conference composed of academic clinicians and researchers, practicing clinicians, administrators, consumers, and families was convened to develop evidence- based consensus algorithms for the pharmacotherapy of major depressive disorder in the Texas mental health system. After a series of presentations and panel discussions, the consensus panel met and drafted the algorithms. Results: The panel consensually agreed on algorithms developed for both nonpsychotic and psychotic depression. The algorithms consist of systematic strategies to define appropriate treatment interventions and tactics to assure optimal implementation of the strategies. Subsequent to the consensus process, the algorithms were further modified and expanded iteratively to facilitate implementation on a local basis. Conclusion: These algorithms serve as the initial foundation for the development and implementation of medication treatment algorithms for patients treated in public mental health systems. Specific issues related to adaptation, implementation, feasibility testing, and evaluation of outcomes with the pharmacotherapeutic algorithms will be described in future articles.",
author = "Crismon, {M. Lynn} and Madhukar Trivedi and Pigott, {Teresa A.} and Rush, {A. John} and Hirschfeld, {Robert M A} and Kahn, {David A.} and Charles DeBattista and Nelson, {J. Craig} and Nierenberg, {Andrew A.} and Sackeim, {Harold A.} and Thase, {Michael E.}",
year = "1999",
month = "3",
language = "English (US)",
volume = "60",
pages = "142--156",
journal = "Journal of Clinical Psychiatry",
issn = "0160-6689",
publisher = "Physicians Postgraduate Press Inc.",
number = "3",

}

TY - JOUR

T1 - The Texas medication algorithm project

T2 - Report of the Texas consensus conference panel on medication treatment of major depressive disorder

AU - Crismon, M. Lynn

AU - Trivedi, Madhukar

AU - Pigott, Teresa A.

AU - Rush, A. John

AU - Hirschfeld, Robert M A

AU - Kahn, David A.

AU - DeBattista, Charles

AU - Nelson, J. Craig

AU - Nierenberg, Andrew A.

AU - Sackeim, Harold A.

AU - Thase, Michael E.

PY - 1999/3

Y1 - 1999/3

N2 - Background: This article describes the development of consensus medication algorithms for the treatment of patients with major depressive disorder in the Texas public mental health system. To the best of our knowledge, the Texas Medication Algorithm Project (TMAP) is the first attempt to develop and prospectively evaluate consensus-based medication algorithms for the treatment of individuals with severe and persistent mental illnesses. The goals of the algorithm project are to increase the consistency of appropriate treatment of major depressive disorder and to improve clinical outcomes of patients with the disorder. Method: A consensus conference composed of academic clinicians and researchers, practicing clinicians, administrators, consumers, and families was convened to develop evidence- based consensus algorithms for the pharmacotherapy of major depressive disorder in the Texas mental health system. After a series of presentations and panel discussions, the consensus panel met and drafted the algorithms. Results: The panel consensually agreed on algorithms developed for both nonpsychotic and psychotic depression. The algorithms consist of systematic strategies to define appropriate treatment interventions and tactics to assure optimal implementation of the strategies. Subsequent to the consensus process, the algorithms were further modified and expanded iteratively to facilitate implementation on a local basis. Conclusion: These algorithms serve as the initial foundation for the development and implementation of medication treatment algorithms for patients treated in public mental health systems. Specific issues related to adaptation, implementation, feasibility testing, and evaluation of outcomes with the pharmacotherapeutic algorithms will be described in future articles.

AB - Background: This article describes the development of consensus medication algorithms for the treatment of patients with major depressive disorder in the Texas public mental health system. To the best of our knowledge, the Texas Medication Algorithm Project (TMAP) is the first attempt to develop and prospectively evaluate consensus-based medication algorithms for the treatment of individuals with severe and persistent mental illnesses. The goals of the algorithm project are to increase the consistency of appropriate treatment of major depressive disorder and to improve clinical outcomes of patients with the disorder. Method: A consensus conference composed of academic clinicians and researchers, practicing clinicians, administrators, consumers, and families was convened to develop evidence- based consensus algorithms for the pharmacotherapy of major depressive disorder in the Texas mental health system. After a series of presentations and panel discussions, the consensus panel met and drafted the algorithms. Results: The panel consensually agreed on algorithms developed for both nonpsychotic and psychotic depression. The algorithms consist of systematic strategies to define appropriate treatment interventions and tactics to assure optimal implementation of the strategies. Subsequent to the consensus process, the algorithms were further modified and expanded iteratively to facilitate implementation on a local basis. Conclusion: These algorithms serve as the initial foundation for the development and implementation of medication treatment algorithms for patients treated in public mental health systems. Specific issues related to adaptation, implementation, feasibility testing, and evaluation of outcomes with the pharmacotherapeutic algorithms will be described in future articles.

UR - http://www.scopus.com/inward/record.url?scp=0032901376&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032901376&partnerID=8YFLogxK

M3 - Article

C2 - 10192589

AN - SCOPUS:0032901376

VL - 60

SP - 142

EP - 156

JO - Journal of Clinical Psychiatry

JF - Journal of Clinical Psychiatry

SN - 0160-6689

IS - 3

ER -